% Expired Patents = 20.0

EPO Patents = 2

Forward Citations = 3

Loading Chart...

7 inventors (with patents filed for the assignee):

Luis O Burzio Eriz (3 out of 4 patents)

Veronica A Burzio Menendez (3 out of 4 patents)

Jaime E Villegas Olavarria (3 out of 4 patents)

4. Luis O Burzio (2 out of 10 patents)

5. Jaime E Villegas (2 out of 5 patents)

6. Veronica A Burzio (2 out of 5 patents)

7. Claudio E Villota Arcos (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11319535 - Antisense oligonucleotides for treatment of cancer stem cells (2022-05-03),

2. 10876166 - Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein (2020-12-29),

3. 10457943 - Antisense oligonucleotides for treatment of cancer stem cells (2019-10-29),

4. 10066269 - Methods for detecting and treating multiple myeloma (2018-09-04),

5. 9903000 - Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein (2018-02-27),

Company Overview

Andes Biotechnologies Global, Inc. is a leading biotechnology company focused on developing innovative biopharmaceuticals for various diseases. With a strong emphasis on research and development, Andes Biotechnologies is committed to advancing the field of biotechnology and improving patient outcomes worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#49 in Burlingame, CA

#12,073 in California

#51,644 in US

Burlingame, CA, United States of America

Andes Biotechnologies Global, Inc.

Forward Citations = 3

7 inventors:

Luis O Burzio Eriz (3 out of 4 patents)

Veronica A Burzio Menendez (3 out of 4 patents)

Jaime E Villegas Olavarria (3 out of 4 patents)

4. Luis O Burzio (2 out of 10 patents)

5. Jaime E Villegas (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Andes Biotechnologies Global, Inc.. Retrieved from https://idiyas.com/company/andes-biotechnologies-global

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]